14 completed, 2 terminated, 2 unknown. 18 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 14, Terminated 2, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow Coronary Arteriosclerosis: new trials by email Literature Review of Coronary Arteriosclerosis trials Research Report on Coronary Arteriosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis injection of 68Ga-DOTATATE - Coronary Arteriosclerosis | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 12 | 2019-11-21 | 2022-06-30 |
| Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)? omega 3 - Coronary Arteriosclerosis | Phase 3 | Unknown | Shiraz University of Medical Sciences | 90 | 2012-02-01 | 2013-01-29 |
| Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI) omega 3 - Coronary Arteriosclerosis | Phase 3 | Completed | Shahid Beheshti University of Medical Sciences | 104 | 2012-01-01 | 2012-12-10 |
| Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device Manual Compression, Vascular Closure Device - Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis | Phase 3 | Completed | Cordis US Corp. | 488 | 2007-02-01 | 2012-06-01 |
| Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent Percutaneous coronary intervention with Taxus stent - Coronary Arteriosclerosis | Phase 3 | Completed | French Cardiology Society | 155 | 2005-12-01 | 2011-01-04 |
| A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention Prasugrel, Clopidogrel - Coronary Arteriosclerosis, Acute Coronary Syndromes | Phase 3 | Completed | Eli Lilly and Company | 13619 | 2004-11-01 | 2010-09-16 |
| Estrogen, HDL, and Coronary Heart Disease in Women Estrogens, Conjugated (USP), Medroxyprogesterone 17-Acetate, Placebo - Cardiovascular Diseases, Coronary Disease | Phase 2 / Phase 3 | Completed | Tufts University | 309 | 2004-03-01 | 2016-04-21 |
| A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease torcetrapib/atorvastatin, atorvastatin - Coronary Disease, Coronary Arteriosclerosis | Phase 3 | Completed | Pfizer | 1100 | 2003-10-01 | 2007-12-10 |
| Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response Cell saver, No cell saver - Systemic Inflammatory Response Syndrome, Coronary Arteriosclerosis | Phase 3 | Terminated | Copenhagen University Hospital, Rigshospitalet | 30 | 2003-01-01 | 2008-01-14 |
| A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) Rosuvastatin calcium - Coronary Arteriosclerosis | Phase 3 | Completed | AstraZeneca | 450 | 2002-11-01 | 2010-11-19 |
| Copenhagen Arterial Revascularization Randomized Patency and Outcome Trial Total arterial revascularization, Conventional revascularization - Coronary Arteriosclerosis, Ischemic Heart Disease | Phase 3 | Unknown | Copenhagen University Hospital, Rigshospitalet | 331 | 2002-02-01 | 2008-02-15 |
| Radial Artery Versus Saphenous Vein Patency (RSVP) Study Coronary artery bypass graft (CABG) surgery - Coronary Arteriosclerosis | Phase 3 | Completed | Imperial College London | 142 | 1998-05-01 | 2019-06-25 |
| Women's Angiographic Vitamin and Estrogen Trial (WAVE) estrogen replacement therapy, estrogens, conjugated, progesterone - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1996-08-01 | 2016-07-12 | |
| Estrogen and Graft Atherosclerosis Research Trial (EAGER) hormone replacement therapy, estrogens, medroxyprogesterone - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1996-08-01 | 2016-02-18 | |
| Estrogen Replacement and Atherosclerosis (ERA) in Older Women estrogen replacement therapy, hormone replacement therapy, estrogens - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1994-08-01 | 2016-03-16 | |
| Familial Atherosclerosis Treatment Study lovastatin, colestipol, niacin - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | University of Washington | 146 | 1984-01-01 | 2015-12-03 |
| Stanford Coronary Risk Intervention Project (SCRIP) smoking cessation, diet, reducing, exercise - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | Stanford University | 1983-09-01 | 2016-01-12 | |
| Cholesterol-Lowering Atherosclerosis Study (CLAS) colestipol, niacin, diet, fat-restricted - Arterial Occlusive Diseases, Cardiovascular Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1980-06-01 | 2013-12-13 |
Coronary Artery Disease (18) · Coronary Disease (8) · Cardiovascular Diseases (7) · Heart Diseases (7) · Myocardial Ischemia (7) · Atherosclerosis (2) · Acute Coronary Syndrome (1) · Angina Pectoris (1) · Arterial Occlusive Diseases (1) · Carotid Artery Diseases (1) · Cerebrovascular Disorders (1) · Hyperlipidemias (1) · Intracranial Arteriosclerosis (1) · Systemic Inflammatory Response Syndrome (1)
Arteriosclerosis (18) · Vascular Diseases (18) · Arterial Occlusive Diseases (17) · Cardiovascular Diseases (11) · Heart Diseases (11) · Myocardial Ischemia (11) · Coronary Disease (10) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chest Pain (1) · Dyslipidemias (1) · Inflammation (1) · Intracranial Arterial Diseases (1) · Lipid Metabolism Disorders (1)
Hormone Replacement Therapy (3) · Colestipol (2) · Diet, Fat-Restricted (2) · Docosahexaenoic Acids (2) · Estrogen Replacement Therapy (2) · Estrogens (2) · Estrogens, Conjugated (USP) (2) · Fish Oils (2) · Niacin (2) · Ascorbic Acid (1) · Atorvastatin (1) · Clopidogrel (1) · Coronary Artery Bypass (1) · Diet, Reducing (1) · Dietary Supplements (1)
National Heart, Lung, and Blood Institute (NHLBI) (4) · Copenhagen University Hospital, Rigshospitalet (2) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Cordis US Corp. (1) · Eli Lilly and Company (1) · French Cardiology Society (1) · Imperial College London (1) · Pfizer (1) · Shahid Beheshti University of Medical Sciences (1) · Shiraz University of Medical Sciences (1) · Stanford University (1) · Tufts University (1) · University of Washington (1)
United States (5) · France (3) · Belgium (2) · Canada (2) · Denmark (2) · Iran (2) · Netherlands (2) · Spain (2) · Australia (1) · Italy (1) · Poland (1) · United Kingdom (1)
Sune Damgaard, MD (2) · B. Greg Brown, M.D., Ph.D (1) · David Blankenhorn (1) · David Herrington (1) · David M Herrington, MD (1) · Edwin Alderman (1) · Jamshid Salamzadeh, PhD (1)
PMID 16533939, PMID 16722590, PMID 17387129, PMID 17982182, PMID 18174456, PMID 18377975, PMID 18498956, PMID 18506009, PMID 18757948, PMID 19029466, PMID 19106084, PMID 19155011, PMID 19249633, PMID 19270315, PMID 19489872, PMID 19695549, PMID 19699846, PMID 20026770, PMID 20580029, PMID 20713903, PMID 20723851, PMID 21606391, PMID 22199016, PMID 22633653, PMID 22995726, PMID 23134549, PMID 24140678, PMID 24947719, PMID 30975005, PMID 32164882, PMID 35224730
2017 (1), N01HV68165 (1), N01HV68166 (1), N01HV68167 (1), N01HV68168 (1), N01HV68169 (1), N01HV68170 (1), P01HL023619 (1), P01HL030086 (1), R01HL028292 (1), R01HL070081 (1), U01HL049488 (1), U01HL050840 (1)